approval
saveIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
March 5, 2026updated 5mo ago
community read0 votes
Sponsor: TEVA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMar 5, 2026
- approvalGABAPENTIN: GABAPENTIN — FDA approvalMar 6, 2026
- approvalALDACTAZIDE: TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
- approvalALDACTAZIDE: TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
- approvalALDACTAZIDE: TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
- approvalALDACTAZIDE: TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 17, 2026
comments(0)
5-min edit window · permanent after that